πŸ‡ΊπŸ‡Έ FDA
Patent

US 6538025

Aminoindan derivatives

expired A61PA61P25/00A61P25/28

Quick answer

US patent 6538025 (Aminoindan derivatives) held by TEVA PHARMACEUTICAL INDUSTRIES, LTD. expires Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
TEVA PHARMACEUTICAL INDUSTRIES, LTD.
Grant date
Tue Mar 25 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 20 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
28
CPC classes
A61P, A61P25/00, A61P25/28